Eloxx Pharmaceuticals (ELOX) 10-Q2014 Q1 Quarterly report

Filed: 14 Nov 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Good

New words: Bayer, book, Brassica, Browne, carryforward, considerable, CropScience, de, deferred, deprioritized, disallowance, discounted, diversity, drought, duly, formatted, Fred, fully, furnished, goal, greenhouse, herewith, Hutchinson, iii, InVigor, iv, justified, left, Leslie, low, nitrogen, nutrient, platform, President, published, Restated, retroactively, revert, salinity, schedule, seed, settle, split, stop, substantively, surprised, tax, thereof, thereunto, undersigned, unrecognized, withholding, wrote, XBRL

Removed: andin, ATM, bortezomib, breakdown, combining, Designation, designing, dividend, eliminated, eliminating, Emerging, end, equal, eradication, estimation, evidence, exceeded, expression, extinguishment, forty, fundamental, guide, Holder, increasing, inhibit, inhibition, input, issuable, likelihood, liver, maximum, Meristem, MKT, monotherapy, morbidity, mortality, multiplied, NFkB, NYSE, observation, occurring, optimal, organ, Rahan, ranging, reclassified, reinforce, reset, revalued, serum, significance, silencing, smaller, Specifically, strike, studiesin, survived, table, Task, threshold, toxicity, uncertainty, undiscounted, unobservable, weight

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ELOX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Senesco Technologies, Inc. for the period ended September 30, 2013 as filed with the Securities and Exchange Commission on the date hereof, the undersigned, Leslie J. Browne, Ph.D., President and Chief Executive Officer, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

(1) The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Senesco Technologies, Inc.

Dated: November 14, 2013	/s/ Leslie J. Browne *
	Leslie J. Browne, Ph.D.
	President and Chief Executive Officer
	(Principal Executive Officer)

* A signed original of this written statement required by Section 906 has been provided to us and will be retained by us and furnished to the Securities and Exchange Commission or its staff upon request.